Squarepoint Ops LLC decreased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 74.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,930 shares of the company's stock after selling 39,754 shares during the period. Squarepoint Ops LLC's holdings in Prestige Consumer Healthcare were worth $1,088,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC acquired a new position in shares of Prestige Consumer Healthcare in the fourth quarter valued at approximately $84,932,000. Raymond James Financial Inc. acquired a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $42,593,000. Norges Bank bought a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $40,009,000. Bessemer Group Inc. grew its holdings in Prestige Consumer Healthcare by 10,053.1% during the 4th quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock worth $23,041,000 after acquiring an additional 292,144 shares during the last quarter. Finally, Boston Trust Walden Corp increased its position in Prestige Consumer Healthcare by 43.5% in the 4th quarter. Boston Trust Walden Corp now owns 831,627 shares of the company's stock valued at $64,942,000 after acquiring an additional 252,089 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.
Prestige Consumer Healthcare Trading Down 0.6%
PBH traded down $0.48 during trading on Tuesday, reaching $85.01. 128,388 shares of the stock traded hands, compared to its average volume of 297,860. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The stock's 50-day moving average is $83.60 and its 200 day moving average is $82.44. Prestige Consumer Healthcare Inc. has a 12 month low of $63.02 and a 12 month high of $90.04. The stock has a market capitalization of $4.20 billion, a PE ratio of 19.91, a P/E/G ratio of 2.69 and a beta of 0.44.
Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The company had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. During the same quarter in the prior year, the company earned $1.02 EPS. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.
Wall Street Analysts Forecast Growth
PBH has been the topic of a number of recent research reports. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Royal Bank of Canada raised Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, May 17th. Oppenheimer increased their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research note on Thursday, February 13th. Finally, DA Davidson lifted their price objective on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $93.33.
Read Our Latest Stock Report on Prestige Consumer Healthcare
Insider Transactions at Prestige Consumer Healthcare
In related news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now owns 17,157 shares in the company, valued at $1,544,130. The trade was a 8.91% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.60% of the company's stock.
About Prestige Consumer Healthcare
(
Free Report)
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Featured Stories
Before you consider Prestige Consumer Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.
While Prestige Consumer Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
